Upgrade to SI Premium - Free Trial

Acadia Pharma (ACAD)

21.75 +0.03 (0.14%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/11/26)

Latest Headlines

Form 4 ACADIA PHARMACEUTICALS For: May 29 Filed by: Baker Brothers Life Sciences LP June 2, 2026 4:33 PM - SEC Filing Form 4 ACADIA PHARMACEUTICALS For: May 29 Filed by: HARRIGAN EDMUND June 1, 2026 6:00 PM - SEC Filing Form 4 ACADIA PHARMACEUTICALS For: May 29 Filed by: Ndu Adora June 1, 2026 6:00 PM - SEC Filing Form 4 ACADIA PHARMACEUTICALS For: May 29 Filed by: GAROFALO ELIZABETH A. June 1, 2026 6:00 PM - SEC Filing Form 4 ACADIA PHARMACEUTICALS For: May 29 Filed by: Daly James M June 1, 2026 6:00 PM - SEC Filing Form 4 ACADIA PHARMACEUTICALS For: May 29 Filed by: Poole Jonathan June 1, 2026 6:00 PM - SEC Filing Form 4 ACADIA PHARMACEUTICALS For: May 29 Filed by: Brege Laura June 1, 2026 6:00 PM - SEC Filing Form 8-K ACADIA PHARMACEUTICALS For: May 29 May 29, 2026 4:06 PM - SEC Filing Form 4 ACADIA PHARMACEUTICALS For: May 26 Filed by: Kihara James May 27, 2026 6:00 PM - SEC Filing Form 144 ACADIA PHARMACEUTICALS Filed by: Kihara James May 26, 2026 4:06 PM - SEC Filing Canaccord Reiterates Buy Rating on Acadia Pharmaceuticals (ACAD) May 7, 2026 6:29 AM - StreetInsider Form 10-Q ACADIA PHARMACEUTICALS For: Mar 31 May 7, 2026 6:06 AM - SEC Filing Form 8-K ACADIA PHARMACEUTICALS For: May 06 May 6, 2026 4:51 PM - SEC Filing Acadia Pharma (ACAD) Misses Q1 EPS by 3c ; Offers Guidance May 6, 2026 4:07 PM - StreetInsider Acadia Pharmaceuticals Reports First Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance May 6, 2026 4:05 PM - BizWire Form 4 ACADIA PHARMACEUTICALS For: May 01 Filed by: Kihara James May 5, 2026 6:00 PM - SEC Filing Form 4 ACADIA PHARMACEUTICALS For: May 01 Filed by: Schneyer Mark C. May 5, 2026 6:00 PM - SEC Filing Form 8-K ACADIA PHARMACEUTICALS For: Apr 27 May 1, 2026 9:19 AM - SEC Filing Acadia Pharmaceuticals Announces Planned Year-End Retirement of Elizabeth H.Z. Thompson, Ph.D., Head of Research and Development, Following a Distinguished Career April 30, 2026 4:05 PM - BizWire Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences April 28, 2026 4:05 PM - BizWire Form SCHEDULE 13G ACADIA PHARMACEUTICALS Filed by: VANGUARD PORTFOLIO MANAGEMENT LLC April 28, 2026 3:54 PM - SEC Filing Acadia Pharmaceuticals (ACAD) PT Lowered to $38 at Needham April 24, 2026 8:44 AM - StreetInsider Form ARS ACADIA PHARMACEUTICALS For: Dec 31 April 24, 2026 6:02 AM - SEC Filing Form DEF 14A ACADIA PHARMACEUTICALS For: May 29 April 24, 2026 6:02 AM - SEC Filing Acadia Pharmaceuticals to Present Data at the 2026 American Academy of Neurology (AAN) Annual Meeting April 17, 2026 9:05 AM - BizWire Acadia Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 6, 2026 April 15, 2026 4:05 PM - BizWire Form 4 ACADIA PHARMACEUTICALS For: Apr 05 Filed by: Schneyer Mark C. April 7, 2026 7:57 PM - SEC Filing Form 4 ACADIA PHARMACEUTICALS For: Apr 05 Filed by: Kihara James April 7, 2026 7:56 PM - SEC Filing Acadia Pharmaceuticals Announces DAYBUE® STIX (trofinetide) is Now Broadly Available in the United States for the Treatment of Rett Syndrome April 7, 2026 10:01 AM - BizWire ACADIA Pharmaceuticals launches powder formulation of Rett syndrome drug April 7, 2026 9:08 AM - StreetInsider Acadia Pharmaceuticals (ACAD) PT Lowered to $29 at RBC Capital April 7, 2026 9:02 AM - StreetInsider Form 4 ACADIA PHARMACEUTICALS For: Mar 24 Filed by: Rhodes Jennifer J March 26, 2026 8:00 PM - SEC Filing Form 4 ACADIA PHARMACEUTICALS For: Mar 24 Filed by: Thompson Elizabeth H.Z. March 26, 2026 8:00 PM - SEC Filing Form 4 ACADIA PHARMACEUTICALS For: Mar 24 Filed by: Owen Adams Catherine March 26, 2026 8:00 PM - SEC Filing Form 4 ACADIA PHARMACEUTICALS For: Mar 24 Filed by: Schneyer Mark C. March 26, 2026 8:00 PM - SEC Filing Form 4 ACADIA PHARMACEUTICALS For: Mar 24 Filed by: Kihara James March 26, 2026 8:00 PM - SEC Filing Form SCHEDULE 13G/A ACADIA PHARMACEUTICALS Filed by: VANGUARD GROUP INC March 26, 2026 3:07 PM - SEC Filing BofA Securities Upgrades Acadia Pharmaceuticals (ACAD) to Buy March 25, 2026 6:05 AM - StreetInsider RBC Capital on Acadia Pharmaceuticals (ACAD): 'Setup Skews Net Favorably' March 24, 2026 5:54 AM - StreetInsider Form 4 ACADIA PHARMACEUTICALS For: Mar 03 Filed by: Poole Jonathan March 20, 2026 6:01 PM - SEC Filing Form 3 ACADIA PHARMACEUTICALS For: Mar 03 Filed by: Poole Jonathan March 20, 2026 6:00 PM - SEC Filing RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns' March 18, 2026 9:21 AM - StreetInsider Acadia Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum March 12, 2026 4:05 PM - BizWire Form 4 ACADIA PHARMACEUTICALS For: Mar 06 Filed by: Kihara James March 10, 2026 6:00 PM - SEC Filing Form 4 ACADIA PHARMACEUTICALS For: Mar 06 Filed by: Owen Adams Catherine March 10, 2026 6:00 PM - SEC Filing Form 4 ACADIA PHARMACEUTICALS For: Mar 06 Filed by: Garner Thomas March 10, 2026 6:00 PM - SEC Filing Form 4 ACADIA PHARMACEUTICALS For: Mar 06 Filed by: Thompson Elizabeth H.Z. March 10, 2026 6:00 PM - SEC Filing Form 4 ACADIA PHARMACEUTICALS For: Mar 06 Filed by: Rhodes Jennifer J March 10, 2026 6:00 PM - SEC Filing Form 4 ACADIA PHARMACEUTICALS For: Mar 06 Filed by: Schneyer Mark C. March 10, 2026 6:00 PM - SEC Filing Full Article List